Lumina℠ has been developed by a group of nationally recognized physicians and scientists in an effort to deliver a scientific approach to cannabinoid medicine. Our easy-to-use platform accumulates both self-reported and physician encounter patient data. 

Lumina℠ scientifically approaches cannabis by tracking and analyzing patient data. It generates statistics that will provide the information needed to make an appropriate cannabinoid molecule selection for peak efficacy. It is also a proprietary, SaaS based EMR enhancer that provides daily practice and multiple clinical trial capability options.

Lumina℠ is fully HIPAA compliant, with encrypted, highly secure databases and servers.  No one has access to any patient identifying information unless given express permission by the patient.